GRP
IOVA icon

Global Retirement Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Global Retirement Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499 Buy
+120
New +$456 ﹤0.01% 4283
2025
Q4 		– Sell
-5
Closed -$11 – 4337
2025
Q3 		$11 Hold
5
– – ﹤0.01% 3849
2025
Q2 		$9 Buy
+5
New +$12 ﹤0.01% 3790
2022
Q2 		– Sell
-83
Closed -$1K – 2781
2022
Q1 		$1K Buy
+83
New +$1.28K ﹤0.01% 2421

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Global Retirement Partners's IOVA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 120 shares worth $499. The stake represents ﹤0.01% of the portfolio and ranks #4283 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in IOVA as recently as Q3 2025.

Global Retirement Partners first reported a position in IOVA in Q1 2022 and has held it in 4 quarters since. The position peaked at $1K in Q1 2022. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Global Retirement Partners held 120 shares of Iovance Biotherapeutics worth $499 as of Q2 2026.
  • Iovance Biotherapeutics was a new Global Retirement Partners position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4283 holding.
  • Global Retirement Partners first reported a position in Iovance Biotherapeutics in Q1 2022 and has held it in 4 quarters since.
  • Global Retirement Partners's Iovance Biotherapeutics position peaked at $1K in Q1 2022.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.